Status:
COMPLETED
Fluorescence and Reflectance Spectroscopy During Colposcopy in Detecting Cervical Intraepithelial Neoplasia and Dysplasia in Healthy Participants With a History of Normal Pap Smears
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cervical Cancer
Precancerous Condition
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
RATIONALE: New diagnostic procedures such as fluorescence and reflectance spectroscopy (shining light on tissue and measuring patterns of light reflected) may improve the ability to noninvasively dete...
Detailed Description
OBJECTIVES: * Identify potential improvements in noninvasive methods of diagnosing dysplasia and neoplasia of the cervix using fluorescence and reflectance spectroscopy in healthy participants with a...
Eligibility Criteria
Inclusion
- Subjects will be individuals 18 years of age or older, who have voluntarily responded to advertisement in the form of posted flyers or word of mouth.
- Subjects must sign an informed consent indicating awareness of the investigational nature of this study.
Exclusion
- 1\) Pregnant individuals will be ineligible for this study.
Key Trial Info
Start Date :
April 1 1998
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
1070 Patients enrolled
Trial Details
Trial ID
NCT00084903
Start Date
April 1 1998
End Date
February 1 2009
Last Update
August 2 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
M. D. Anderson Cancer Center at University of Texas
Houston, Texas, United States, 77030-4009
2
British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada, V5Z 4E6